InnovAge to Announce Fourth Quarter and Fiscal 2024 Financial Results and Host Conference Call Tuesday, September 10, 2024

Published on August 27, 2024

DENVER, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today

Continue reading on website
Other news

InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center

August 20, 2024
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”) announced today that its Board of Directors has approved a share repurchase program (the “Program”) that authorizes the Company to repurchase up to $5.0 million of its common stock.

Path to Production: How Process Development Can Streamline your Biologic’s Development

August 28, 2024
The success of developing biological drugs – such as monoclonal antibodies (mAbs) and other complex biologics – hinges not just on the initial breakthrough, but also on consistent production at a scale that meets the quality standards required for clinical trials and commercialization. This is where process development comes into play.Process development is the backbone of biopharmaceutical manufa